| 1 |
Ronald Knegtel |
Vertex Pharmaceuticals Incorporated |
112 |
| 2 |
Andrew Miller |
Vertex Pharmaceuticals Incorporated |
68 |
| 3 |
Frederick Arthur Brookfield |
Cardioxyl Pharmaceuticals |
65 |
| #4 |
Stephen Martin Courtney |
Cardioxyl Pharmaceuticals |
52 |
| #5 |
Juan-Miguel Jimenez |
Vertex Pharmaceuticals Incorporated |
46 |
| #5 |
Damien Fraysse |
Vertex Pharmaceuticals Incorporated |
46 |
| #7 |
Pierre-Henri Storck |
Vertex Pharmaceuticals Incorporated |
43 |
| #8 |
Francoise Pierard |
Vertex Pharmaceuticals Incorporated |
41 |
| #9 |
Julian M. C. Golec |
Vertex Pharmaceuticals Incorporated |
40 |
| #10 |
Lisa Marie Frost |
Cardioxyl Pharmaceuticals |
38 |
| #10 |
Robert Slade |
Tokamak Energy |
38 |
| #12 |
David Festus Charles Moffat |
Chroma Therapeutics |
32 |
| #12 |
Bent Karsten Jakobsen |
Immunocore Limited |
32 |
| #12 |
Andrew Humphris |
Infinitesima Limited |
32 |
| #15 |
Mark Peter Ridgill |
Merck |
26 |
| #15 |
Michael Prime |
Chdi Foundation |
26 |
| #17 |
Alan Hornsby Davidson |
British Biotechnology |
25 |
| #17 |
Craig Johnstone |
Astrazeneca Ab |
25 |
| #19 |
Jonathan Mark Bentley |
Vernalis Research Limited |
22 |
| #20 |
Graham Michael Wynne |
Oxagen Limited |
21 |
| #21 |
Gorka Etxebarria I Jardi |
Vertex Pharmaceuticals Incorporated |
19 |
| #22 |
Sharn Ramaya |
Vertex Pharmaceuticals Incorporated |
18 |
| #23 |
Alistair Rutherford |
Vertex Pharmaceuticals Incorporated |
17 |
| #23 |
Nicholas Salvatore Arini |
Google |
17 |
| #23 |
Peter Eamon Molloy |
Immunocore Limited |
17 |
| #23 |
Victor Alexandrovich Kalinin |
Transense Technologies, Plc |
17 |
| #27 |
Ian Bell |
Infineum International Limited |
16 |
| #27 |
Alan Bond |
Reaction Engines |
16 |
| #29 |
Francis Xavier Wilson |
Hoffmann-La Roche |
15 |
| #29 |
Mark James Batchelor |
Vertex Pharmaceuticals Incorporated |
15 |
| #29 |
Pui Leng Loke |
BOE |
15 |
| #29 |
Brian William Davies |
ExxonMobil |
15 |
| #33 |
Christian Rohlff |
Oxford Biotherapeutics |
14 |
| #33 |
James Leighton |
Snap |
14 |
| #33 |
Luke Alphey |
Oxitec |
14 |
| #33 |
Shazia Sadiq |
Vertex Pharmaceuticals Incorporated |
14 |
| #33 |
William Macklin |
Nexeon Limited |
14 |
| #33 |
Clive D. Telford |
Emcon Technologies |
14 |
| #33 |
Naomi Went |
Chdi Foundation |
14 |
| #40 |
Nathaniel Julius Thomas Monck |
Vernalis Research Limited |
13 |
| #40 |
Rebecca Quaggin-Mitchell |
IBM |
13 |
| #40 |
Ralph Lamble |
Oval Medical Technologies Limited |
13 |
| #40 |
Richard Heap |
Faradion Limited |
13 |
| #40 |
Daryl Simon Walter |
Glaxo Group Limited |
13 |
| #45 |
Russell Peter Gore |
— |
12 |
| #45 |
Alan Hastings Drummond |
British Biotech Pharmaceuticals |
12 |
| #45 |
Paul Beasley |
Siemens Aktiengesellschaft |
12 |
| #45 |
Alexander Heifetz |
Epix Delaware |
12 |
| #45 |
Christopher Michael Friend |
Nexeon Limited |
12 |
| #45 |
Karl Peter Welna |
Sharp Kabushiki Kaisha |
12 |